Comparison Study of Family Practice Interventions for Depression in Adults

Not Applicable

Completed

• Conditions: Depression

• Registration Number: NCT01975207
• Lead Sponsor: AHS Cancer Control Alberta

Brief Summary

To determine if treatment of significant depressive symptoms identified in individuals attending a family practice improves either psychiatric outcome, overall health care costs, or Quality of Life (QOL). Two previously developed treatment approaches - an internet-based approach and a comprehensive depression pathway - will be compared to two control groups (those who have treatment as usual after screening for depression and measurement of QOL, and a second control group who will have QOL data only collected). The investigators hope to help Alberta Health Services identify which approach is best as rapidly as possible so that the best approach can be implemented throughout the province of Alberta.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-10-29
• Study Start: 2013-11
• Study First Submitted QC: 2013-11-01
• Study First Posted: 2013-11-03
• Primary Completion: 2015-05-05
• Study Completion: 2015-05-05
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-28
• Last Update Posted: 2020-07-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1489

Inclusion Criteria

• Adults aged 18 and above
• Cognitively capable of independently understanding and confirming their desire to take part

Exclusion Criteria

• 18 and under
• Cognitively incapable of independently understanding and confirming their desire to take part

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Primary Outcome Measures

Name	Time	Method
Reduction in depression scores in those patients who have one of the two treatment interventions	12 weeks	We expect a reduction in depression scores in those patients who have one of the two treatment interventions (Groups #3 and #4) over a 12-week period, compared to those who are screened for depression, but only receive treatment as usual (Group #2).

Secondary Outcome Measures

Name	Time	Method
Reduction in total health care costs	12 weeks/12 months	We expect a reduction in total health care costs in the two treatment groups compared both to those who are not screened for depression (Group #1) and those who are screened for depression, but only receive treatment as usual (Group #2). This will be a within-subject comparison for total health care costs in the 12-weeks prior to the index visit compared to the total health care costs in the 12-weeks following the index visit. Mid-term costs will also be compared between groups for the 12-month period following the index visit. Examples of costs included are the number of doctors visits, any ambulance rides or emergency room visits and lab tests. The data collected will not include any diagnosis or results and will only be used for economic analysis. This data will be owned by the University of Alberta, will not be saved in medical records and no one but the study staff will have access to the data unless authorized by a governement agency or ethics board.